Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaempferol Emulgel for Female Sexual Dysfunction
NCT06060691Phase 1Completed
- Sponsor
- Deraya University
- Start
- Sep 2023
- Primary completion
- Dec 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in female sexual interest/arousal disorder (FSIAD) comparing Kaempferol group with Placebo group (2 arms). Primary endpoint: Female Sexual Function Index at 2 months. Started Sep 2023; status: completed.
02
Drugs
kaempferol
03
Conditions
female sexual interest/arousal disorder (FSIAD)
Beyond the preview
Go deeper on NCT06060691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06060691.